Oxygen Self‐Supply Engineering‐Ferritin for the Relief of Hypoxia in Tumors and the Enhancement of Photodynamic Therapy Efficacy
Source abstract
Abstract
Abstract Hypoxia is a hallmark of the tumor microenvironment (TME) that promotes tumor development and metastasis. Photodynamic therapy (PDT) is a promising strategy in the treatment of tumors, but it is limited by the lack of oxygen in TME. In this work, an O2 self‐supply PDT system is constructed by co‐encapsulation of chlorin e6 (Ce6) and a MnO2 core in an engineered ferritin (Ftn), generating a nanozyme promoted PDT nanoformula (Ce6/Ftn@MnO2) for tumor therapy. Ce6/Ftn@MnO2 exhibits a uniform small size (15.5 nm) and high stability due to the inherent structure of Ftn. The fluorescence imaging and immunofluorescence analysis demonstrate the pronounced accumulation of Ce6/Ftn@MnO2 in the tumors of mice, and the treatment significantly decreases the expression of hypoxia‐inducible factor (HIF)‐1α. The Ce6/Ftn@MnO2 nanoplatform exerts a more potent anti‐tumor efficacy with negligible damage to normal tissues compared to the treatment with free Ce6. Moreover, the weak acidity and the presence of H2O2 in TME significantly enhances the r1 relativity of Ce6/Ftn@MnO2, resulting in a prominent enhancement of MRI imaging in the tumor. This bio‐mimic Ftn strategy not only improves the in vivo distribution and retention of Ce6, but also enhances the effectiveness and precision of PDT by TME modulation.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Cancer, Hypoxia, and Metabolism
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmacy The First Affiliated Hospital of USTC Division of Life Sciences and Medicine Department of Chemistry University of Science and Technology of China Hefei 230001 China
High Magnetic Field Laboratory Chinese Academy of Sciences Hefei 230031 China
Funding
National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities
References (66)
Show source-provided references
1. 10.1038/nrc107110.1038/nrc1071 ↗
2. 10.1021/ja508679h10.1021/ja508679h ↗
3. 10.1021/acsnano.5b0424310.1021/acsnano.5b04243 ↗
4. 10.1021/cr500419810.1021/cr5004198 ↗
5. 10.1002/adma.20190189310.1002/adma.201901893 ↗
6. 10.1002/adma.20160190210.1002/adma.201601902 ↗
7. 10.3322/caac.2011410.3322/caac.20114 ↗
8. 10.1038/nrc189410.1038/nrc1894 ↗
9. 10.1093/jnci/90.12.88910.1093/jnci/90.12.889 ↗
10. 10.1039/b108586g10.1039/b108586g ↗
11. 10.1039/C6CS00616G10.1039/C6CS00616G ↗
12. 10.1038/ncomms559610.1038/ncomms5596 ↗
13. 10.1021/acsami.0c0103910.1021/acsami.0c01039 ↗
14. 10.1002/smtd.20200056610.1002/smtd.202000566 ↗
15. 10.1002/anie.20200511110.1002/anie.202005111 ↗
16. 10.1038/nrc118710.1038/nrc1187 ↗
17. 10.1038/nrc136710.1038/nrc1367 ↗
18. 10.1038/nrc70410.1038/nrc704 ↗
19. 10.1002/adma.20170609010.1002/adma.201706090 ↗
20. 10.1021/ja511420n10.1021/ja511420n ↗
21. 10.1039/C6CS00592F10.1039/C6CS00592F ↗
22. 10.7150/thno.5334610.7150/thno.53346 ↗
23. 10.1002/anie.20201715210.1002/anie.202017152 ↗
24. 10.1021/ja502936410.1021/ja5029364 ↗
25. 10.1002/adma.20140257210.1002/adma.201402572 ↗
26. 10.1002/adfm.20180380410.1002/adfm.201803804 ↗
27. 10.1002/adfm.20160425810.1002/adfm.201604258 ↗
28. 10.1021/acsnano.5b0677910.1021/acsnano.5b06779 ↗
29. 10.1002/adfm.20160067610.1002/adfm.201600676 ↗
30. 10.1021/nn405773r10.1021/nn405773r ↗
31. 10.1002/adma.20140514110.1002/adma.201405141 ↗
32. 10.1002/adfm.20140451110.1002/adfm.201404511 ↗
33. 10.1002/ange.20141141710.1002/ange.201411417 ↗
34. 10.1016/j.matt.2019.03.00710.1016/j.matt.2019.03.007 ↗
35. 10.1002/smtd.20200056610.1002/smtd.202000566 ↗
36. 10.1002/adma.20140091410.1002/adma.201400914 ↗
37. 10.1021/ja200746p10.1021/ja200746p ↗
38. 10.1021/nl903313r10.1021/nl903313r ↗
39. 10.1038/nnano.2012.9010.1038/nnano.2012.90 ↗
40. 10.1021/acsami.8b2094210.1021/acsami.8b20942 ↗
41. 10.1002/adma.20210312810.1002/adma.202103128 ↗
42. 10.1016/j.addr.2021.11389210.1016/j.addr.2021.113892 ↗
43. 10.1002/adfm.20210200410.1002/adfm.202102004 ↗
44. 10.1016/j.jconrel.2019.09.00210.1016/j.jconrel.2019.09.002 ↗
45. 10.1039/C1CC15189D10.1039/C1CC15189D ↗
46. 10.1021/acsnano.5b0752110.1021/acsnano.5b07521 ↗
47. 10.1126/science.269.5220.5410.1126/science.269.5220.54 ↗
48. 10.1002/anie.20090473110.1002/anie.200904731 ↗
49. 10.1039/C1CC15189D10.1039/C1CC15189D ↗
50. 10.1021/cr400011b10.1021/cr400011b ↗
51. 10.7150/thno.3982710.7150/thno.39827 ↗
52. 10.1016/j.jconrel.2020.06.02610.1016/j.jconrel.2020.06.026 ↗
53. 10.1073/pnas.140780811110.1073/pnas.1407808111 ↗
54. 10.1038/nrc311010.1038/nrc3110 ↗
55. 10.1158/0008-5472.CAN-05-419310.1158/0008-5472.CAN-05-4193 ↗
56. 10.1016/j.matlet.2006.07.16510.1016/j.matlet.2006.07.165 ↗
57. 10.1038/sj.cr.731007210.1038/sj.cr.7310072 ↗
58. 10.1007/s10541-005-0102-710.1007/s10541-005-0102-7 ↗
59. 10.1021/acs.nanolett.6b0426910.1021/acs.nanolett.6b04269 ↗
60. 10.1002/adma.20200224610.1002/adma.202002246 ↗
61. 10.1021/jacs.9b0345710.1021/jacs.9b03457 ↗
62. 10.1002/anie.20140847610.1002/anie.201408476 ↗
63. Yuan F. · Cancer Res. · 1995 · 55 · 3752
64. 10.1073/pnas.95.8.460710.1073/pnas.95.8.4607 ↗
65. 10.1016/j.addr.2010.04.00910.1016/j.addr.2010.04.009 ↗
66. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗